Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MabVax Therapeutics Holdings Inc (OTCQB:MBVX)

1.90
Delayed Data
As of Aug 04
 -0.11 / -5.47%
Today’s Change
0.83
Today|||52-Week Range
15.00
+4.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.000.00314.2K
 
 
Depreciation And Amortization10.0K1.0K0.0012.2K
 
 
 
 
 
Operating ExpensesGross Income-10.0K-1.0K0.00--
 
 
 
General Expenses12.0M8.0M5.2M8.7M
 
 
 
 
 
Research And Development5.6M3.5M2.0M3.5M
 
 
 
 
 
Total Operating Expenses12.1M8.0M5.2M8.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.1M-8.0M-5.2M-8.4M
 
 
 
 
 
Extraordinary Credit0.000.00--475.4K
 
 
Other Expenses0.000.000.00-379.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.0M-8.0M-5.2M-7.9M
 
 
 
 
 
Preferred Dividend0.000.000.00-2.7M
 
 
Net Income-12.0M-8.0M-5.2M-7.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS224.7K273.5K560.0K1.1M
 
 
 
 
 
Shares To Calculate EPS Diluted224.7K273.5K560.0K1.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$52.80-$29.12-$9.36-$9.51
 
 
 
 
 
EPS Diluted-$52.80-$29.12-$9.36-$9.51